Research output per year
Research output per year
Fingerprint
Dive into the research topics where Ana Brandusa Pavel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases
Pavel, A. B., Del Duca, E., Cheng, J., Wu, J., Ungar, B., Estrada, Y. D., Jack, C., Maari, C., Proulx, É. S. C., Ramirez-Valle, F., Krueger, J. G., Bissonnette, R. & Guttman-Yassky, E., Jan 2023, In: Allergy: European Journal of Allergy and Clinical Immunology. 78, 1, p. 178-191 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
No association between dupilumab use and short-term cancer development in atopic dermatitis patients
Owji, S., Ungar, B., Dubin, D. P., Poplausky, D., Young, J. N., Ghalili, S., Han, J., Srinivasan, D., Packer, S., Pavel, A. B., Correa da Rosa, J., Guttman-Yassky, E. & Gulati, N., 2023, (Accepted/In press) In: Journal of Allergy and Clinical Immunology: In Practice.Research output: Contribution to journal › Article › peer-review
-
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes
Renert-Yuval, Y., Correa da Rosa, J., Garcet, S., Pavel, A. B., Bares, J., Chima, M., Hawkes, J. E., Gilleaudeau, P., Sullivan-Whalen, M., Singer, G. K., Krueger, J. G. & Guttman-Yassky, E., Oct 2022, In: British Journal of Dermatology. 187, 4, p. 539-547 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI
Kim, H. J., Del Duca, E., Pavel, A. B., Singer, G. K., Abittan, B. J., Chima, M. A., Kimmel, G., Bares, J., Baum, D., Gagliotti, M., Genece, J., Chu, J., Lebwohl, M. G. & Guttman-Yassky, E., 2022, (Accepted/In press) In: Archives of Dermatological Research.Research output: Contribution to journal › Article › peer-review
-
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
Ungar, B., Glickman, J. W., Golant, A. K., Dubin, C., Marushchak, O., Gontzes, A., Mikhaylov, D., Singer, G. K., Baum, D., Wei, N., Sanin, A., Gruenstein, D., Lebwohl, M. G., Pavel, A. B. & Guttman-Yassky, E., Jan 2022, In: Journal of Allergy and Clinical Immunology: In Practice. 10, 1, p. 134-142 9 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations
Press / Media
-
Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin Disease Summit
6/12/18 → 7/12/18
9 items of Media coverage
Press/Media
-
Dermavant Sciences to Present New Data on Cerdulatinib for Atopic Dermatitis and Vitiligo at the 3rd Annual Inflammatory Skin ...
6/12/18
1 item of Media coverage
Press/Media